- Clear All
- Remove theEpidemiologyfilter Epidemiology
- Remove theImmunologyfilter Immunology
- Remove theToxicologyfilter Toxicology
- Remove the2012filter 2012
- Remove theBiosecurityfilter Biosecurity
- Remove theNational legislation & regulationfilter National legislation & regulation
- Remove theProduction medicinefilter Production medicine
Your search for 'Production medicine' has returned 3 results
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
JAVMA news
New policy addresses FMD outbreak scenario
As a proactive move, the AVMA Executive Board approved a new policy during its Nov. 15-17, 2012, meeting that will be sent to the federal government…